The FY2023 (Dec) proxy of Outset Medical names 18 peer companies for pay. Among Outset Medical and these peers, CEO pay was 6th highest of 8 and total shareholder return was the lowest of 8.
6th highest of 8in Outset Medical and its pay peers, FY2023 (Dec) by CEO pay:
$2.9M$10.2M
8th highest of 8in Outset Medical and its pay peers, FY2023 (Dec) by total shareholder return:
$9$191
Pay peer group, FY2023 (Dec) proxy
| Staar Surgical | ||
| AtriCure | ||
| GLAUKOS | ||
| Pacific Biosciences Of California | ||
| Veracyte | ||
| CareDx | ||
| Tactile Systems Technology | ||
| Axonics, Inc. | Not disclosed | Not disclosed |
| Inari Medical, Inc. | Not disclosed | Not disclosed |
| Inspire Medical Systems | Not disclosed | Not disclosed |
| NanoString Technologies, Inc. | Not disclosed | Not disclosed |
| PhenomeX Inc. (formerly Berkeley Lights, Inc.) | Not disclosed | Not disclosed |
| Pulmonx Corporation | Not disclosed | Not disclosed |
| SI-BONE, Inc. | Not disclosed | Not disclosed |
| Shockwave Medical, Inc. | Not disclosed | Not disclosed |
| Silk Road Medical, Inc. | Not disclosed | Not disclosed |
| ViewRay, Inc. | Not disclosed | Not disclosed |
| iRhythm Technologies, Inc. | Not disclosed | Not disclosed |
'%3e%3cpath%20id='Clip_2-2'%20data-name='Clip%202'%20d='M0,0H26.3V33.111H0Z'%20fill='none'/%3e%3cg%20id='Group_3-2'%20data-name='Group%203'%20clip-path='url(%23clip-path)'%3e%3cpath%20id='Fill_1'%20data-name='Fill%201'%20d='M6.339,33.111H0V0H14.853a11.855,11.855,0,0,1,8.171,3.075A10.318,10.318,0,0,1,26.3,10.69c0,6.121-4.921,10.737-11.447,10.737H6.339V33.11Zm0-27.246v9.7h8.514a4.743,4.743,0,0,0,4.825-4.873,4.719,4.719,0,0,0-4.825-4.825Z'%20transform='translate(0)'%20fill='%23af0678'/%3e%3c/g%3e%3c/g%3e%3cpath%20id='Fill_4'%20data-name='Fill%204'%20d='M11.967,26.015C5.145,26.015,0,20.423,0,13.008S5.145,0,11.967,0a11.5,11.5,0,0,1,7.474,2.7V.709h5.865v24.6H19.441V23.32A11.5,11.5,0,0,1,11.967,26.015Zm.757-20.1A6.8,6.8,0,0,0,6.1,13.008a6.8,6.8,0,0,0,6.622,7.1,6.384,6.384,0,0,0,4.712-2.04,7.345,7.345,0,0,0,1.91-5.055,7.343,7.343,0,0,0-1.91-5.055A6.385,6.385,0,0,0,12.724,5.913Z'%20transform='translate(27.858%208.987)'%20fill='%23af0678'/%3e%3cpath%20id='Fill_6'%20data-name='Fill%206'%20d='M0,13.008A12.71,12.71,0,0,1,13.008,0,12.739,12.739,0,0,1,25.164,8.135L19.252,9.886a6.694,6.694,0,0,0-6.244-3.973,6.9,6.9,0,0,0-6.906,7.1,6.9,6.9,0,0,0,6.906,7.1,6.694,6.694,0,0,0,6.244-3.973l5.912,1.75a12.739,12.739,0,0,1-12.156,8.135A12.71,12.71,0,0,1,0,13.008'%20transform='translate(57.277%208.987)'%20fill='%23af0678'/%3e%3cpath%20id='Fill_8'%20data-name='Fill%208'%20d='M16.981,33.111H0V0H16.035a10.949,10.949,0,0,1,7.308,2.584,8.514,8.514,0,0,1,2.909,6.45,8.342,8.342,0,0,1-3.217,6.67,9.148,9.148,0,0,1,4.635,7.947A8.9,8.9,0,0,1,24.6,30.4,11.442,11.442,0,0,1,16.981,33.111ZM6.339,19.015v8.231H16.981a4.031,4.031,0,0,0,2.9-1.189,4.26,4.26,0,0,0,0-5.853,4.031,4.031,0,0,0-2.9-1.188Zm0-13.15V13.2h9.7a3.621,3.621,0,0,0,2.6-1.047,3.713,3.713,0,0,0,1.041-2.643,3.562,3.562,0,0,0-3.642-3.642Z'%20transform='translate(86.317%201.182)'%20fill='%23e31b92'/%3e%3cpath%20id='Clip_11-2'%20data-name='Clip%2011'%20d='M0,35H160V0H0Z'%20fill='none'/%3e%3cg%20id='Mask_Group_1'%20data-name='Mask%20Group%201'%20clip-path='url(%23clip-path-2)'%3e%3cpath%20id='Fill_10'%20data-name='Fill%2010'%20d='M6.717,34.293H.8V9.7H6.717v24.6ZM3.737,7.52A3.678,3.678,0,0,1,0,3.737,3.655,3.655,0,0,1,3.737,0,3.678,3.678,0,0,1,7.521,3.737,3.785,3.785,0,0,1,6.445,6.444,3.787,3.787,0,0,1,3.737,7.52Z'%20transform='translate(117.532)'%20fill='%23e31b92'/%3e%3cpath%20id='Fill_12'%20data-name='Fill%2012'%20d='M31.293,15.647A15.647,15.647,0,1,1,15.647,0,15.646,15.646,0,0,1,31.293,15.647'%20transform='translate(128.707%203.71)'%20fill='%23e31b92'/%3e%3c/g%3e%3c/svg%3e)
18 companies
PSU comparator group
The companies that relative total shareholder return is measured against for performance stock units.
| Russell 2000 Medical Device Index (index) | Not disclosed | Not disclosed |
1 company
Changes by year
FY2025 (Dec) proxy
- RemovedAtriCurepay peer groupRemoved AtriCure, Inc., Glaukos Corporation, STAAR Surgical Company, TransMedics Group, Inc. and Veracyte, Inc., each of which exceeded the updated market capitalization filtering criteria range
- RemovedAxonics, Inc.pay peer groupRemoved Axonics, Inc., NanoString Technologies, Inc. and Silk Road Medical, Inc., each of which was acquired during 2024
- RemovedGLAUKOSpay peer groupRemoved AtriCure, Inc., Glaukos Corporation, STAAR Surgical Company, TransMedics Group, Inc. and Veracyte, Inc., each of which exceeded the updated market capitalization filtering criteria range
- RemovedInari Medical, Inc.pay peer groupRemoved Inari Medical, Inc. and iRhythm Technologies, Inc., each of which exceeded both the updated market capitalization and revenue filtering criteria ranges; and
- RemovedNanoString Technologies, Inc.pay peer groupRemoved Axonics, Inc., NanoString Technologies, Inc. and Silk Road Medical, Inc., each of which was acquired during 2024
- RemovedStaar Surgicalpay peer groupRemoved AtriCure, Inc., Glaukos Corporation, STAAR Surgical Company, TransMedics Group, Inc. and Veracyte, Inc., each of which exceeded the updated market capitalization filtering criteria range
- RemovedSilk Road Medical, Inc.pay peer groupRemoved Axonics, Inc., NanoString Technologies, Inc. and Silk Road Medical, Inc., each of which was acquired during 2024
- RemovedTransMedics Grouppay peer groupRemoved AtriCure, Inc., Glaukos Corporation, STAAR Surgical Company, TransMedics Group, Inc. and Veracyte, Inc., each of which exceeded the updated market capitalization filtering criteria range
- RemovedVeracytepay peer groupRemoved AtriCure, Inc., Glaukos Corporation, STAAR Surgical Company, TransMedics Group, Inc. and Veracyte, Inc., each of which exceeded the updated market capitalization filtering criteria range
- RemovediRhythm Technologies, Inc.pay peer groupRemoved Inari Medical, Inc. and iRhythm Technologies, Inc., each of which exceeded both the updated market capitalization and revenue filtering criteria ranges; and
FY2023 (Dec) proxy
- AddedViewRay, Inc.pay peer groupin order to offset some of the larger companies in the peer group, replace the removal of Intersect ENT, Inc. and maintain our target peer group size
- RemovedIntersect ENT, Inc.pay peer groupRemoved Intersect ENT, Inc. as it was acquired during 2022; and
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.